Synaptic circuit mechanisms underlying psilocybin's therapeutic effects in the stressed brain
Project Number1R01MH136381-01A1
Former Number1R01MH136381-01
Contact PI/Project LeaderZUO, YI
Awardee OrganizationUNIVERSITY OF CALIFORNIA SANTA CRUZ
Description
Abstract Text
PROJECT SUMMARY
Psychedelics are chemicals best known for their ability to induce profound changes in the human
conscious experience. After a several-decade hiatus, research on psychedelics is undergoing a renaissance,
driven by their potential to treat psychiatric disorders with rapid onset and enduring effect. Recent research
reveals that psychedelics can rapidly promote the structural and functional plasticity of synapses, leading to the
conjecture that neural plasticity underlies their long-term therapeutic values. However, the neurobiological
mechanisms remain largely elusive. Our overarching goal is to understand the cellular and circuit mechanisms
underlying psychedelics’ long-lasting therapeutic effects. In this proposal, we focus on the classical serotonergic
psychedelic psilocybin and investigate how it rescues the deleterious effects of stress, a major risk factor for
many neuropsychiatric disorders. Our central hypothesis is that psilocybin affects the brain at multiple levels,
from synaptic plasticity to the functional network; although psilocybin only transiently enhances synapse
formation, it permanently alters the synaptic circuit in an experience-dependent manner; the incorporation of new
synapses into the neural circuit is essential for psilocybin’s long-lasting rescue of stress-induced functional and
behavioral deficits. Specifically, in Aim 1, we will determine the acute and enduring effects of psilocybin on the
stressed brain, particularly on the structural reorganization of synaptic circuits, on cortical functional networks,
and on the representation of behavioral variables by cortical neuronal ensembles. Aim 2 determines how the
environmental and behavioral contexts in which psilocybin is administered impact its rescuing effects on the
stressed brain. Aim 3 determines the contribution of psilocybin-induced neuroplasticity, particularly the
stabilization of newly formed dendritic spines, to its rescuing effects on the stressed brain. Overall, these studies
will provide an integrated, mechanistic understanding of psilocybin’s rescuing effects across the organizational
hierarchy of the brain, from molecules and synapses to circuits and functional networks, and lay the foundation
for its clinical application in treating stress-related psychiatric disorders.
Public Health Relevance Statement
PROJECT NARRATIVE
This proposal studies how the classical psychedelic psilocybin rescues the deleterious effects of chronic
stress, a major risk factor for mental illnesses. We investigate psilocybin’s effects across the brain’s
organizational hierarchy, from synapses and neural circuits to large-scale cortical networks and ultimately mouse
behavior. Such studies will reveal the fundamental mechanisms of psychedelics’ impact on brain and behavior
and provide an integrated, mechanistic foundation for their applications in psychiatry.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAffectAnimal ModelAttentionBehaviorBehavior TherapyBehavioralBrainBrain regionCalciumChemicalsChronic stressClinicalClinical TrialsCognitiveConsciousDefectDendritic SpinesDependenceExcitatory SynapseFoundationsGeneticGoalsHallucinogensHourHousingHumanImageKnock-in MouseKnowledgeLeftMedialMental disordersMicroscopyModificationMusNeuronal PlasticityNeuronsPharmaceutical PreparationsPrefrontal CortexProtein IsoformsPsilocybinPsychiatryPsychotherapyRecovery of FunctionRenaissanceResearchRisk FactorsRoleSafetySensorySignaling MoleculeSiteStressSynapsesSynaptic plasticityTestingTherapeuticTherapeutic EffectUnited States Food and Drug AdministrationVertebral columnVisualizationbehavioral outcomecalmodulin-dependent protein kinase IIcatalystclinical applicationdosageenvironmental enrichment for laboratory animalsexperienceexperimental studyflexibilityfunctional plasticityimaging geneticsin vivoin vivo imaginginformation processinginterestmemory consolidationmouse geneticsneuralneural circuitneurobiological mechanismneuronal circuitryneuropathologyneuropsychiatric disorderpostsynapticsmall moleculesustained recoverysynaptogenesistemporal measurementtooltreatment-resistant depressiontwo-photon
No Sub Projects information available for 1R01MH136381-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01MH136381-01A1
Patents
No Patents information available for 1R01MH136381-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01MH136381-01A1
Clinical Studies
No Clinical Studies information available for 1R01MH136381-01A1
News and More
Related News Releases
No news release information available for 1R01MH136381-01A1
History
No Historical information available for 1R01MH136381-01A1
Similar Projects
No Similar Projects information available for 1R01MH136381-01A1